HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers
Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety, tolerability and pharmacokinetics of HEC53856 after single or
multiple oral administration, as well as the food effect on the pharmacokinetics, in healthy
non-elderly subjects.